Mettler Toledo International (MTD) EBT Margin (2009 - 2026)
Mettler Toledo International (MTD) posted quarterly EBT Margin of 28.17% for Q2 2026, up 288.0% year-over-year from 7.26% in Q2 2025, and up 27.26% on a QoQ basis from 22.14% in Q1 2026.
Mettler Toledo International (MTD) EBT Margin (2009 - 2026) Analysis & Trends
Mettler Toledo International has reported EBT Margin for 18 years, with the latest figure at 28.17% in Q2 2026.
- EBT Margin for Q2 2026 came in at 28.17%, up 288.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 26.55% (up 6.0% YoY), and the FY2025 annual result was 26.05%, down 73.0% from the prior year.
- EBT Margin grew to 28.17% in Q2 2026, from 22.14% in the prior quarter.
- Over five years, EBT Margin peaked at 30.73% in Q4 2022 and troughed at 22.14% in Q1 2026.
- A 5-year average of 26.21% and a median of 26.19% in 2022 frame the typical range for EBT Margin.
- The widest annual swing landed in 2023, when EBT Margin slumped 586 bps; it then surged 522 bps in 2024.
- A 5-year view of EBT Margin shows it stood at 30.73% in 2022, then slipped by 19 bps to 24.87% in 2023, then increased by 21 bps to 30.1% in 2024, then retreated by 3 bps to 29.13% in 2025, then decreased by 3 bps to 28.17% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 28.17% in Q2 2026, 22.14% in Q1 2026, and 29.13% in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.92 Bn | 209.86 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 140.37 Bn | 136.02 Bn | 3.61 Bn | 17.21% |
| 3 | Idexx Laboratories | 46.17 Bn | 45.97 Bn | 779.09 Mn | 34.29% |
| 4 | Agilent Technologies | 39.76 Bn | 37.96 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 39.41 Bn | 37.33 Bn | 1.44 Bn | 6.89% |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn | -12.17% |
| 7 | Illumina | 30.07 Bn | 28.90 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.62 Bn | 28.56 Bn | 650.22 Mn | 28.17% |
| 9 | Quest Diagnostics | 26.15 Bn | 25.53 Bn | 1.03 Bn | 13.54% |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn | 9.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.17% |
| Mar 31, 2026 | 22.14% |
| Dec 31, 2025 | 29.13% |
| Sep 30, 2025 | 26.15% |
| Jun 30, 2025 | 25.29% |
| Mar 31, 2025 | 22.85% |
| Dec 31, 2024 | 30.10% |
| Sep 30, 2024 | 27.13% |
| Jun 30, 2024 | 25.69% |
| Mar 31, 2024 | 23.82% |
| Dec 31, 2023 | 24.87% |
| Sep 30, 2023 | 26.65% |
| Jun 30, 2023 | 26.82% |
| Mar 31, 2023 | 24.40% |
| Dec 31, 2022 | 30.73% |
| Sep 30, 2022 | 27.98% |
| Jun 30, 2022 | 26.24% |
| Mar 31, 2022 | 23.73% |
| Dec 31, 2021 | 27.57% |
| Sep 30, 2021 | 26.01% |